… of putative biomarkers, less than 100 biomarkers have been validated for clinical practice …
It has been highlighted that the journey of a new biomarker from the bench to the bedside is …

… It is substantial to discover novel biomarkers with diagnostic, … novel, non-invasive biomarkers
in favor of BC diagnosis and … of miRNAs as valuable biomarkers to predict response to …

… Third, heterogeneity in laboratory assays not approved for clinical use could cause significant
variations in biomarker verification trials. For example, CXC chemokine motif ligand 9 (…

… 3 biomarker-defined entities with 3 clinical syndromes commonly associated with AD: clinically
… We found that the prevalence of biological AD (defined by the A+T+ biomarker profile) is …

… Good clinical manufacturing processes need to be established for a swift clinical translation.
… Although MI improves diagnosis by assessing one or a few key biomarkers of a certain …

… clinical manifestations: mild cognitive impairment, dementia, and probable AD. 1 Notably, this
asymptomatic prevalence of brain load biomarker … and pathological biomarkers to achieve …

… The incorporation of surrogate biomarkers into current clinical … and clinical validation (as
well as clinical utility) of candidate surrogates,72 and, finally, integration into prospective clinical …

… clinical trials but no reliable biomarkers to predict clinical benefit currently exist. For some
cancer types, biomarkers … may act as natural biomarkers for clinical efficiency if the right factors …

… and clinically useful after immersing themselves in studying the association between genes
and clinical … More importantly, robustness is essential for any clinical test. It is better to use a …

… was compared with peptide biomarkers of chronic … clinical impacts include new clinical
measures that derive from omics research but that do not involve omics measures in the clinical …